Back
Madrigal Pharmaceuticals Stock Price Chart
Sponsored
MDGL
Sponsored
Could This Stock Under $5 Be Your Biggest Opportunity?
Click here to learn more.
Sell
43
MDGL
Madrigal Pharmaceuticals
Last Price:
$317.44
Seasonality Move:
-6.73%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bearish and MDGL is experiencing slight selling pressure.
Madrigal Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 309.04 | Sell |
20-day SMA: | 310.05 | Sell |
50-day SMA: | 300.58 | Buy |
200-day SMA: | 258.83 | Buy |
8-day EMA: | 309.83 | Sell |
20-day EMA: | 309.89 | Sell |
50-day EMA: | 298.04 | Buy |
200-day EMA: | 262.08 | Buy |
Madrigal Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.27 | Buy |
Relative Strength Index (14 RSI): | 50.25 | Buy |
Chaikin Money Flow: | -80744 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (302.71 - 326.17) | Sell |
Bollinger Bands (100): | (219.66 - 313.6) | Buy |
Madrigal Pharmaceuticals Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Madrigal Pharmaceuticals Stock
Is Madrigal Pharmaceuticals Stock a Buy?
-
Madrigal Pharmaceuticals share price is 308.57 while MDGL 8-day simple moving average is 309.04, which is a Sell signal.
-
The stock price of MDGL is 308.57 while Madrigal Pharmaceuticals 20-day SMA is 310.05, which makes it a Sell.
-
Madrigal Pharmaceuticals 50-day simple moving average is 300.58 while MDGL share price is 308.57, making it a Buy technically.
-
MDGL stock price is 308.57 and Madrigal Pharmaceuticals 200-day simple moving average is 258.83, creating a Buy signal.
MDGL Technical Analysis vs Fundamental Analysis
Sell
43
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy or a Sell?
-
Madrigal Pharmaceuticals stock is rated a SellThe current Madrigal Pharmaceuticals [MDGL] share price is $308.57. The Score for MDGL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Madrigal Pharmaceuticals Stock Info
Market Cap:
6.7B
Price in USD:
308.57
Share Volume:
198.7K
Madrigal Pharmaceuticals 52-Week Range
52-Week High:
368.29
52-Week Low:
168.25
Sell
43
Madrigal Pharmaceuticals (MDGL)
is a Sell
Madrigal Pharmaceuticals Share Price Forecast
-
What is the Madrigal Pharmaceuticals stock price today?The Madrigal Pharmaceuticals stock price is 308.57 USD today.
-
Will MDGL stock go up or go down?Madrigal Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Madrigal Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Madrigal Pharmaceuticals is overvalued.
Is Madrigal Pharmaceuticals Stock a Buy?
-
Madrigal Pharmaceuticals share price is 308.57 while MDGL 8-day exponential moving average is 309.83, which is a Sell signal.
-
The stock price of MDGL is 308.57 while Madrigal Pharmaceuticals 20-day EMA is 309.89, which makes it a Sell.
-
Madrigal Pharmaceuticals 50-day exponential moving average is 298.04 while MDGL share price is 308.57, making it a Buy technically.
-
MDGL stock price is 308.57 and Madrigal Pharmaceuticals 200-day simple moving average is 262.08, creating a Buy signal.
Fundamental Analysis of Madrigal Pharmaceuticals
Is Madrigal Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $4.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.27 per share, and an increase next year of $15.85 per share.
Technical Analysis of Madrigal Pharmaceuticals
Should I short Madrigal Pharmaceuticals stock?
-
MDGL Moving Average Covergence Divergence (MACD) indicator is 1.27, suggesting Madrigal Pharmaceuticals is a Buy
-
Madrigal Pharmaceuticals Relative Strength Index (RSI) is 50.25, which suggest Madrigal Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Madrigal Pharmaceuticals is (302.71 - 326.17), which suggest Madrigal Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Madrigal Pharmaceuticals is (219.66 - 313.6), which suggest Madrigal Pharmaceuticals is a Buy
* Madrigal Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.